Pfizer starts late-stage trial phases of COVID-19 antiviral pill for kids 6-17

Pfizer started late-stage trials of Paxlovid in children ages 6 to 17.  The COVID-19 antiviral pill will be evaluated for the safety and efficacy of treatment in kids considered to be at risk for severe disease.